Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Solid1on Dec 16, 2024 4:51am
92 Views
Post# 36363600

RE:RE:RE:RE:RE:RE:RE:FORMAL TAKEOVER BID.

RE:RE:RE:RE:RE:RE:RE:FORMAL TAKEOVER BID.
In the last 10 years, 400 INDs in the field of cannabis and CBD have been submitted to the FDA!
If I remember correctly, GW Pharma received IND status in 2013 and was approved in 2018, but the road back then was much rockier than it is today. The market has huge potential and there are very few manufacturers so far. Medipharm Labs has already stated that they are working with various pharmaceutical companies in the US and Brazil to bring drugs through approval. So yes, something should really come soon, I am firmly convinced of that. 
<< Previous
Bullboard Posts
Next >>